Satoshi Nishida
Overview
Explore the profile of Satoshi Nishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
641
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sasaki Y, Matsuo T, Watanabe Y, Iwatsuki M, Inahashi Y, Nishida S, et al.
J Antibiot (Tokyo)
. 2024 Nov;
78(2):90-105.
PMID: 39578618
Porphyromonas gingivalis, a Gram-negative anaerobic bacterium, is a key pathogen in chronic periodontitis. P. gingivalis has a type IX secretion system (T9SS) that secretes highly hydrolytic proteinases called gingipains for...
2.
Nishida S, Ono Y
New Microbes New Infect
. 2024 Nov;
62:101484.
PMID: 39559178
Background: Carbapenem-resistant is of increasing global concern because infections are challenging to treat with standard antibiotics. Here, we identified a previously uncharacterised sp. clinical isolate as co-producing IMP-1 and OXA-58....
3.
Hayashi R, Kaji S, Matsumoto Y, Nishida S, Nishimoto S, Takahashi H
Psychiatry Clin Neurosci
. 2024 Aug;
78(11):687-695.
PMID: 39194166
Aim: Patients with schizophrenia typically exhibit symptoms of disorganized thought and display concreteness and over-inclusion in verbal reports, depending on the level of abstraction. While concreteness and over-inclusion may appear...
4.
Kimura Y, Hatayama N, Sato Y, Nishida S, Yoshino Y
Jpn J Infect Dis
. 2024 Jan;
77(3):178-181.
PMID: 38296540
Multidrug-resistant Acinetobacter baumannii (MDRAB) is an important pathogen that causes nosocomial infections and is resistant to almost all antibiotics, including carbapenems. Cefiderocol is a novel siderophore cephalosporin active against a...
5.
Nishida S, Ono Y
J Infect Public Health
. 2023 Dec;
17(2):293-298.
PMID: 38150808
The occurrence of multidrug-resistant Acinetobacter baumannii (MDRA) has increased rapidly and is associated with severe nosocomial infections. MDRA has emerged in the hospital setting and has evolved into extensively drug-resistant...
6.
Yamanaka Y, Ikeda S, Hatakeyama E, Sabanai K, Tanaka H, Nishida S, et al.
J Bone Miner Metab
. 2023 May;
41(4):557-566.
PMID: 37247111
Introduction: The Seamless Treatment of Osteoporosis against Fractures (STOP-Fx) study was initiated to provide and continue therapeutic interventions for registered patients with osteoporotic fractures. Materials And Methods: Women who visited...
7.
Matsumoto Y, Nishida S, Hayashi R, Son S, Murakami A, Yoshikawa N, et al.
Schizophr Bull
. 2022 Dec;
49(2):498-506.
PMID: 36542452
Objectives: Schizophrenia is a mental illness that presents with thought disorders including delusions and disorganized speech. Thought disorders have been regarded as a consequence of the loosening of associations between...
8.
Nishida S, Ihashi Y, Yoshino Y, Ono Y
Pathology
. 2022 Aug;
54(7):917-921.
PMID: 35934532
Carbapenemase-producing Gram-negative organisms (CPOs) frequently gain multidrug-resistant phenotypes and thereby limit the therapeutic options available. Colonisation and infection with CPOs are critical risks for mortality in clinical settings, especially in...
9.
Niikawa T, Miyahara K, Hamada H, Nishida S
Neurosci Conscious
. 2022 Mar;
2022(1):niac006.
PMID: 35356269
There are many theories of the functions of consciousness. How these theories relate to each other, how we should assess them, and whether any integration of them is possible are...
10.
Tansho-Nagakawa S, Sato Y, Ubagai T, Kikuchi-Ueda T, Kamoshida G, Nishida S, et al.
Pol J Microbiol
. 2022 Jan;
70(4):469-477.
PMID: 35003278
is the main causative pathogen of nosocomial infections that causes severe infections in the lungs. In this study, we analyzed the histopathological characteristics of lung infection with two strains of...